Ad
related to: pfizer patent expirations
Search results
Pfizer sees $10 billion-$15 billion in potential revenue from mRNA vaccines by 2030
Reuters via Yahoo News· 1 year agoIn November, Pfizer had raised its forecast for 2022 sales of its COVID-19 vaccine by $2 billion to...
Decoding Pfizer Inc (PFE): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 3 weeks agoStrengths highlight Pfizer's robust product portfolio and global market presence. Weaknesses underscore the challenges in revenue fluctuations and patent...
Where Will Pfizer Be in 10 Years?
Motley Fool via Yahoo Finance· 4 months agoPfizer (NYSE: PFE) has reached a major transition point. The big pharma company took center stage earlier in the COVID-19 pandemic when it became the...
Here's Why Pfizer Stock Is Looking Increasingly Attractive
Motley Fool· 1 year agoYou might already know the conventional wisdom about Pfizer (NYSE: PFE). The company depends heavily...
Pfizer Is Proving Itself in a Tough Post-Covid Scenario
GuruFocus.com via Yahoo Finance· 2 years agoIn 2021, Pfizer Inc. (NYSE:PFE) succeeded with its coronavirus vaccine, leading to a substantial...
5 Reasons Why Buying This 6%-Yielding Dividend Stock Could Be a Brilliant Move
Motley Fool via Yahoo Finance· 2 months agoPfizer (NYSE: PFE) has seen its better days. Shares of the big drugmaker have plunged more than 50%...
Why Pfizer Is a Much Better Stock Than You Might Think
Motley Fool via Yahoo Finance· 4 months agoI can sum up Pfizer's (NYSE: PFE) stock performance over the last couple of years in one word (and...
Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.
Barrons.com· 2 months agoBARRON'S COVER - MAIN Understanding the products from pharmaceutical companies could be the most...
Better Bull Market Buy: Pfizer vs. Moderna
Motley Fool via Yahoo Finance· 4 months agoCOVID-19 has been especially rough for Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) investors over the last couple of years. Shares of both drugmakers...
Could Pfizer Stock Help You Retire A Millionaire?
Motley Fool via Yahoo Finance· 4 months agoPfizer (NYSE: PFE) ended 2022 with a bang, delivering its highest level of revenue ever -- $100 billion -- thanks to its coronavirus vaccine and...
